Stockreport

Clovis Oncology Presents Data in Advanced Prostate Cancer at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
PDF Findings from Phase 1b RAMP clinical trial lay the groundwork for Phase 3 CASPAR clinical trial evaluating Rubraca® (rucaparib) and Xtandi® (enzalutamide) in combination [Read more]